Yong Qiang Benjamin Tan, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Ischemia | 9 | 2022 | 3128 | 1.540 |
Why?
|
Moyamoya Disease | 2 | 2024 | 250 | 1.370 |
Why?
|
Stroke | 15 | 2024 | 9935 | 1.100 |
Why?
|
Sarcopenia | 1 | 2024 | 370 | 0.650 |
Why?
|
Vitamin K | 2 | 2021 | 321 | 0.640 |
Why?
|
Thrombectomy | 5 | 2022 | 708 | 0.470 |
Why?
|
Fibrinolytic Agents | 7 | 2022 | 2168 | 0.440 |
Why?
|
Cerebrovascular Disorders | 1 | 2020 | 1498 | 0.440 |
Why?
|
Thrombolytic Therapy | 5 | 2022 | 2107 | 0.420 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1293 | 0.370 |
Why?
|
Anticoagulants | 4 | 2022 | 4897 | 0.320 |
Why?
|
Endovascular Procedures | 1 | 2021 | 2137 | 0.280 |
Why?
|
Atrial Fibrillation | 5 | 2023 | 5198 | 0.270 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2022 | 1032 | 0.240 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3087 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3207 | 0.210 |
Why?
|
Thrombosis | 3 | 2023 | 3043 | 0.210 |
Why?
|
Myocardial Infarction | 5 | 2023 | 11888 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 1 | 2024 | 20461 | 0.180 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2021 | 98 | 0.180 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2023 | 578 | 0.180 |
Why?
|
Breast Diseases | 1 | 2023 | 443 | 0.170 |
Why?
|
Treatment Outcome | 11 | 2022 | 64879 | 0.170 |
Why?
|
Migraine with Aura | 1 | 2022 | 203 | 0.170 |
Why?
|
Neck | 1 | 2024 | 730 | 0.170 |
Why?
|
Prevalence | 4 | 2024 | 15641 | 0.150 |
Why?
|
Head | 1 | 2024 | 921 | 0.150 |
Why?
|
Tissue Plasminogen Activator | 2 | 2021 | 1189 | 0.150 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2021 | 346 | 0.140 |
Why?
|
Ischemic Attack, Transient | 1 | 2022 | 899 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 10333 | 0.140 |
Why?
|
Thromboembolism | 1 | 2022 | 1012 | 0.130 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1719 | 0.130 |
Why?
|
Prognosis | 3 | 2024 | 29561 | 0.110 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1284 | 0.110 |
Why?
|
Humans | 27 | 2024 | 759255 | 0.110 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15728 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1448 | 0.100 |
Why?
|
Heart Rate | 1 | 2023 | 4165 | 0.100 |
Why?
|
Delirium | 1 | 2022 | 1653 | 0.090 |
Why?
|
Cerebral Hemorrhage | 1 | 2021 | 2659 | 0.090 |
Why?
|
Aortic Valve Stenosis | 1 | 2022 | 2066 | 0.090 |
Why?
|
Cause of Death | 1 | 2020 | 3721 | 0.090 |
Why?
|
Migraine Disorders | 1 | 2022 | 1691 | 0.080 |
Why?
|
Administration, Oral | 3 | 2022 | 4046 | 0.080 |
Why?
|
Heart Diseases | 1 | 2021 | 2800 | 0.070 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2018 | 2128 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2023 | 15264 | 0.070 |
Why?
|
Intracranial Hemorrhages | 2 | 2022 | 844 | 0.070 |
Why?
|
Blood Glucose | 1 | 2021 | 6368 | 0.070 |
Why?
|
Risk Factors | 6 | 2023 | 74167 | 0.070 |
Why?
|
Incidence | 2 | 2023 | 21336 | 0.060 |
Why?
|
Risk Assessment | 3 | 2023 | 24049 | 0.060 |
Why?
|
Time Factors | 3 | 2023 | 40109 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2021 | 4525 | 0.060 |
Why?
|
Blood Pressure | 1 | 2019 | 8523 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15815 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6649 | 0.050 |
Why?
|
Basilar Artery | 1 | 2022 | 205 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2022 | 80121 | 0.050 |
Why?
|
Colchicine | 1 | 2022 | 261 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8609 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 11833 | 0.040 |
Why?
|
Death | 1 | 2023 | 677 | 0.040 |
Why?
|
Catheters | 1 | 2022 | 426 | 0.040 |
Why?
|
Hemorrhage | 2 | 2022 | 3606 | 0.040 |
Why?
|
Anxiety | 2 | 2023 | 4527 | 0.040 |
Why?
|
Cerebral Infarction | 1 | 2022 | 982 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 12268 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2023 | 21022 | 0.030 |
Why?
|
Aged | 3 | 2023 | 168617 | 0.030 |
Why?
|
Breast | 1 | 2023 | 1979 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 2235 | 0.030 |
Why?
|
Pyridones | 1 | 2018 | 787 | 0.030 |
Why?
|
Middle Aged | 3 | 2023 | 219653 | 0.030 |
Why?
|
Female | 5 | 2023 | 390240 | 0.030 |
Why?
|
Depression | 2 | 2023 | 8026 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2022 | 1799 | 0.030 |
Why?
|
Aortic Valve | 1 | 2022 | 1994 | 0.030 |
Why?
|
Mammography | 1 | 2023 | 2449 | 0.030 |
Why?
|
Male | 4 | 2023 | 358719 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2019 | 1826 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2021 | 1925 | 0.020 |
Why?
|
Stents | 1 | 2022 | 3308 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 2063 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2023 | 3204 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2021 | 3802 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2979 | 0.020 |
Why?
|
Survival Rate | 1 | 2022 | 12800 | 0.020 |
Why?
|
Pyrazoles | 1 | 2018 | 1989 | 0.020 |
Why?
|
Inflammation | 1 | 2023 | 10747 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5880 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2022 | 15672 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13284 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2023 | 58867 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54204 | 0.010 |
Why?
|
Adult | 1 | 2022 | 219390 | 0.000 |
Why?
|